Japan Animal Referral Medical Center Co Ltd
TSE:6039

Watchlist Manager
Japan Animal Referral Medical Center Co Ltd Logo
Japan Animal Referral Medical Center Co Ltd
TSE:6039
Watchlist
Price: 1 370 JPY -2.35%
Market Cap: ¥19.6B

Income Statement

Earnings Waterfall
Japan Animal Referral Medical Center Co Ltd

Income Statement
Japan Animal Referral Medical Center Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
43
43
41
40
39
37
37
31
26
22
17
18
17
17
17
16
16
15
15
14
14
14
13
13
13
12
14
15
17
18
18
18
18
19
20
21
23
0
0
0
Revenue
2 023
N/A
2 093
+3%
2 092
0%
2 123
+2%
2 169
+2%
2 192
+1%
2 228
+2%
2 249
+1%
2 230
-1%
2 259
+1%
2 313
+2%
2 383
+3%
2 499
+5%
2 564
+3%
2 626
+2%
2 676
+2%
2 688
+0%
2 734
+2%
2 764
+1%
2 786
+1%
2 817
+1%
2 848
+1%
2 869
+1%
2 875
+0%
2 947
+3%
2 979
+1%
3 194
+7%
3 457
+8%
3 664
+6%
3 873
+6%
3 890
+0%
3 940
+1%
4 073
+3%
4 270
+5%
4 569
+7%
4 857
+6%
5 097
+5%
5 278
+4%
5 500
+4%
5 742
+4%
Gross Profit
Cost of Revenue
(1 312)
(1 342)
(1 370)
(1 362)
(1 374)
(1 400)
(1 388)
(1 406)
(1 428)
(1 477)
(1 533)
(1 594)
(1 631)
(1 640)
(1 662)
(1 690)
(1 707)
(1 726)
(1 757)
(1 786)
(1 830)
(1 853)
(1 867)
(1 862)
(1 865)
(1 874)
(1 987)
(2 145)
(2 288)
(2 430)
(2 529)
(2 589)
(2 676)
(2 806)
(2 954)
(3 125)
(3 274)
(3 445)
(3 532)
(3 590)
Gross Profit
711
N/A
752
+6%
722
-4%
761
+5%
795
+4%
792
0%
840
+6%
843
+0%
801
-5%
782
-2%
781
0%
789
+1%
868
+10%
924
+6%
963
+4%
987
+2%
981
-1%
1 008
+3%
1 007
0%
999
-1%
987
-1%
995
+1%
1 001
+1%
1 012
+1%
1 082
+7%
1 105
+2%
1 207
+9%
1 312
+9%
1 376
+5%
1 443
+5%
1 361
-6%
1 351
-1%
1 397
+3%
1 464
+5%
1 615
+10%
1 732
+7%
1 823
+5%
1 833
+1%
1 969
+7%
2 152
+9%
Operating Income
Operating Expenses
(506)
(508)
(524)
(525)
(512)
(498)
(497)
(499)
(496)
(502)
(496)
(497)
(508)
(526)
(546)
(564)
(578)
(577)
(586)
(591)
(595)
(589)
(609)
(621)
(642)
(666)
(719)
(762)
(811)
(862)
(880)
(903)
(928)
(967)
(1 007)
(1 044)
(1 081)
(1 112)
(1 138)
(1 191)
Selling, General & Administrative
(506)
(473)
(523)
(525)
(512)
(473)
(497)
(499)
(496)
(487)
(496)
(497)
(508)
(511)
(533)
(551)
(564)
(561)
(586)
(591)
(595)
(572)
(609)
(621)
(642)
(634)
(719)
(762)
(811)
(827)
(880)
(903)
(928)
(937)
(1 007)
(1 044)
(1 081)
(1 081)
(1 138)
(1 191)
Research & Development
0
0
0
0
0
(5)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(9)
0
0
Depreciation & Amortization
0
(26)
0
0
0
(20)
0
0
0
(16)
0
0
0
(16)
0
0
0
(16)
0
0
0
(18)
0
0
0
(33)
0
0
0
(36)
0
0
0
(30)
0
0
0
(22)
0
0
Other Operating Expenses
0
(9)
0
0
0
(0)
0
0
0
(0)
0
0
0
0
(14)
(14)
(14)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
0
(0)
(0)
(0)
(0)
0
0
(0)
(0)
(0)
(0)
(0)
0
(0)
Operating Income
206
N/A
244
+19%
198
-19%
236
+19%
284
+20%
294
+4%
344
+17%
344
+0%
305
-11%
280
-8%
285
+2%
292
+2%
360
+23%
397
+10%
417
+5%
422
+1%
404
-4%
431
+7%
421
-2%
409
-3%
392
-4%
406
+4%
392
-3%
391
0%
441
+13%
439
0%
488
+11%
550
+13%
565
+3%
581
+3%
480
-17%
447
-7%
469
+5%
497
+6%
609
+22%
688
+13%
742
+8%
721
-3%
830
+15%
961
+16%
Pre-Tax Income
Interest Income Expense
(43)
(42)
(41)
(40)
(38)
(37)
(37)
(31)
(27)
(22)
(17)
(18)
(17)
(17)
(17)
(16)
(16)
(15)
(15)
(14)
(14)
(14)
(13)
(13)
(13)
(12)
(14)
(15)
(17)
(18)
(18)
(18)
(18)
(19)
(20)
(21)
(23)
(26)
(29)
(32)
Non-Reccuring Items
(12)
(4)
(12)
(12)
(7)
(19)
(21)
(21)
(21)
(10)
0
0
0
(14)
0
0
0
0
(4)
(5)
(5)
(5)
(2)
(2)
(8)
(16)
(21)
(22)
(21)
(22)
(27)
(28)
(30)
(19)
(10)
(5)
(1)
(2)
(3)
(4)
Gain/Loss on Disposition of Assets
0
0
7
7
7
7
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
1
0
0
0
0
0
6
6
5
6
2
1
2
0
0
0
0
0
0
Total Other Income
28
30
29
27
25
23
7
6
6
5
21
21
24
25
25
26
23
35
35
35
34
25
25
24
18
13
13
16
(13)
(12)
(9)
(11)
27
31
29
28
28
27
29
33
Pre-Tax Income
178
N/A
228
+28%
182
-20%
219
+20%
270
+23%
268
-1%
292
+9%
298
+2%
264
-11%
254
-4%
288
+13%
295
+2%
367
+24%
391
+7%
425
+9%
433
+2%
412
-5%
452
+10%
439
-3%
425
-3%
407
-4%
412
+1%
402
-2%
401
0%
439
+10%
424
-4%
467
+10%
534
+14%
521
-3%
534
+3%
433
-19%
392
-10%
449
+15%
491
+9%
608
+24%
690
+13%
745
+8%
720
-3%
828
+15%
958
+16%
Net Income
Tax Provision
(3)
(13)
(5)
(6)
(12)
(39)
(46)
(51)
(49)
(46)
(48)
(48)
(60)
(96)
(114)
(127)
(134)
(139)
(137)
(136)
(133)
(127)
(124)
(123)
(134)
(137)
(156)
(177)
(178)
(153)
(122)
(111)
(128)
(154)
(186)
(207)
(220)
(199)
(229)
(267)
Income from Continuing Operations
176
215
177
213
259
229
246
247
214
208
241
247
307
295
311
306
278
313
301
289
274
285
279
278
305
287
312
357
343
381
311
281
321
337
422
482
526
521
598
691
Net Income (Common)
176
N/A
215
+22%
177
-17%
213
+20%
259
+21%
229
-11%
246
+7%
247
+0%
214
-13%
208
-3%
241
+16%
247
+3%
307
+24%
295
-4%
311
+5%
306
-2%
278
-9%
313
+13%
301
-4%
289
-4%
274
-5%
285
+4%
279
-2%
278
0%
305
+10%
287
-6%
312
+9%
357
+15%
343
-4%
381
+11%
311
-18%
281
-10%
321
+15%
337
+5%
422
+25%
482
+14%
526
+9%
521
-1%
598
+15%
691
+16%
EPS (Diluted)
14.23
N/A
17.47
+23%
14.39
-18%
17.34
+21%
21.01
+21%
18.63
-11%
19.89
+7%
19.81
0%
17.08
-14%
16.66
-2%
19.06
+14%
19.63
+3%
24.3
+24%
23.4
-4%
24.69
+6%
24.27
-2%
22.06
-9%
24.84
+13%
24.78
0%
23.81
-4%
22.15
-7%
23.39
+6%
22.79
-3%
22.73
0%
24.96
+10%
23.6
-5%
26.2
+11%
30.05
+15%
28.5
-5%
30.64
+8%
22.39
-27%
20.08
-10%
22.95
+14%
24.25
+6%
32.16
+33%
37.39
+16%
40.68
+9%
40.17
-1%
46.29
+15%
53.49
+16%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett